AI and Biotechnology – these two super technologies are combining – World Economic Forum

Financial analysts recognize the massive growth potential of artificial intelligence and biotechnology. But, if anything, the likely economic impact of these sectors is being underestimated, because few have reckoned with the implications of what...

IDT releases new ultra-high performance CRISPR Cas12a enzyme

May 31 2019 As an advocate for the needs of researchers working at the forefronts of genomic research, Integrated DNA Technologies (IDT) releases its latest CRISPR enzyme Alt-R® Cas12a (Cpf1) Ultra. Cas12a Ultra is a...

Life in the Time of Coronavirus

/* custom css */ .td_uid_1_5f08d90f8178c_rand { min-height: 0; } /* custom css */ .td_uid_2_5f08d90f81973_rand { vertical-align: baseline; } REGISTER NOW jQuery(window).load(function () { jQuery('body').find('#td_uid_1_5f08d90f81785 .td-element-style').each(function (index, element) { jQuery(element).css('opacity', 1); return; }); }); ...

Study pinpoints brain cells that trigger sugar cravings and consumption

Credit: Matthew Potthoff, University of Iowa Carver College of Medicine New research has identified the specific brain cells that control how much sugar you eat and how...

Vanquishing the Virus: 160+ COVID-19 Drug and Vaccine Candidates in Development

/* custom css */ .td_uid_1_5e957a936089d_rand { min-height: 0; } /* custom css */ .td_uid_2_5e957a9360a9b_rand { vertical-align: baseline; } While President Trump continues to promote antimalarial drugs such as hydroxychloroquine sulfate and azithromycin to treat COVID-19—“What do...

Global Platelet Rich Plasma (PRP) Market 2019 Top Players:- T-Biotechnology (T-LAB), Arthrex, Inc., Terumo...

A New Industry Research Report ” Platelet Rich Plasma (PRP) Market: Global Industry Analysis, Growth, Stratagies and Forecast 2019- 2025″ gives the Platelet Rich Plasma (PRP) detailed forecast and future prospects around the market. The...

First COVID-19 vaccine found to be safe, able to generate rapid immune response in...

Reviewed by Emily Henderson, B.Sc.May 22 2020 The first COVID-19 vaccine to reach phase 1 clinical trial has been found to be safe, well-tolerated, and able to generate an immune response against SARS-CoV-2 in humans,...

Genome Editing Heads to Primetime

The feverish pace of new discoveries still being made in the genome editing revolution can make it difficult to decipher a quotidian advance from a genuine paradigm shifter. As a result, additions to the...

Global Biotechnology-Based Chemical Market 2019-2025 Technology Strategy Board, Innovation Norway – Market Analyst

Global Biotechnology-Based Chemical Market 2019-2025 investigated the popular scenario within the descriptions, arrangements, applications, and business chain structure. The Biotechnology-Based Chemical Market report additionally focuses on the event trends additionally as history, competitive facet...

VarmX bags €32m in Series B round – European Biotechnology News

Leiden-based coagulant developer VarmX NV has closed a €32m Series B financing to push the Phase II development of VMX-C001, a venom-based modified recombinant Factor X. New investors LSP, Ysios Capital, INKEF Capital and Lundbeckfonden...

Stay connected

50,943FollowersFollow
14,700SubscribersSubscribe

Recent posts

Random article